Apremilast axunio Pharma 30 mg film-coated tablets

Licence status
Authorised: 07/11/2025
Active substances
Apremilast
Dosage Form
Film-coated tablet
Licence number
PA23438/003/002
Licence holder
Axunio Pharma GmbH

Product documents

Licence information

ATC code
L04AA32 apremilast
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
07/11/2025